首页> 外文OA文献 >Modulating p56Lck in T-Cells by a Chimeric Peptide Comprising Two Functionally Different Motifs of Tip fromHerpesvirus saimiri
【2h】

Modulating p56Lck in T-Cells by a Chimeric Peptide Comprising Two Functionally Different Motifs of Tip fromHerpesvirus saimiri

机译:通过嵌合肽调节T细胞中的P56LCK,所述嵌合肽包括两种功能不同的尖端尖端Saimiri的功能不同的基序

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The Lck interacting protein Tip of Herpesvirus saimiri is responsible for T-cell transformation both in vitro and in vivo. Here we designed the chimeric peptide hTip-CSKH, comprising the Lck specific interacting motif CSKH of Tip and its hydrophobic transmembrane sequence (hTip), the latter as a vector targeting lipid rafts. We found that hTip-CSKH can induce a fivefold increase in proliferation of human and Aotus sp. T-cells. Costimulation with PMA did not enhance this proliferation rate, suggesting that hTip-CSKH is sufficient and independent of further PKC stimulation. We also found that human Lck phosphorylation was increased earlier after stimulation when T-cells were incubated previously with hTip-CSKH, supporting a strong signalling and proliferative effect of the chimeric peptide. Additionally, Lck downstream signalling was evident with hTip-CSKH but not with control peptides. Importantly, hTip-CSKH could be identified in heavy lipid rafts membrane fractions, a compartment where important T-cell signalling molecules (LAT, Ras, and Lck) are present during T-cell activation. Interestingly, hTip-CSKH was inhibitory to Jurkat cells, in total agreement with the different signalling pathways and activation requirements of this leukemic cell line. These results provide the basis for the development of new compounds capable of modulating therapeutic targets present in lipid rafts.
机译:Herpesvirus Saimiri的LCK相互作用蛋白尖端在体外和体内负责T细胞转化。在这里,我们设计了嵌合肽HTIP-CSKH,其包含尖端的LCK特异性相互作用基序和其疏水跨膜序列(HTIP),作为靶向脂质筏的载体。我们发现HTIP-CSKH可以诱导人和Aotus SP的增殖的五倍增加。 T细胞。 PMA共刺激并未增强这种增殖率,表明HTIP-CSKH足够且与其他PKC刺激无关。我们还发现,当先前用HTIP-CSKH培养T细胞时,刺激后,人的LCK磷酸化早期增加,支持嵌合肽的强信号和增殖作用。此外,LCK下游信号与HTIP-CSKH明显,但不具有对照肽。重要的是,HTIP-CSKH可以在重量脂质筏膜级分中鉴定,其中在T细胞活化期间存在重要的T细胞信号传导分子(LAT,RAS和LCK)的隔室。有趣的是,HTIP-CSKH与Jurkat细胞的抑制作用,总协议与这种白血病细胞系的不同信号途径和激活要求。这些结果为开发能够调节脂质筏中存在的治疗靶标的新化合物的发展提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号